Skip to content

Why Is My M-Spike Zero? Light Chain Myeloma Explained

Published: | Updated:

A zero M-spike in multiple myeloma usually means you have light chain only multiple myeloma (LCMM). Your cancer cells produce small protein fragments instead of full antibodies, which don't show up as a standard M-spike but are tracked using sensitive blood and 24-hour urine tests.

Key Takeaways

  • Light chain only multiple myeloma (LCMM) accounts for 15-20% of cases and produces small protein fragments rather than fully assembled antibodies.
  • Because these small light chains do not clump together in the blood, standard SPEP tests often show a zero M-spike.
  • Doctors monitor LCMM using highly sensitive Serum Free Light Chain (SFLC) blood assays and 24-hour urine collections.
  • Tracking the ratio of cancerous to healthy light chains in your blood is a primary way to measure how well you are responding to treatment.
  • Light chains are filtered through the kidneys, making regular testing and adequate hydration essential to protect your kidney function.

It is completely normal to feel confused when your lab results show a zero M-spike, but your doctor still diagnoses you with multiple myeloma. The short answer is that you likely have a specific subtype called light chain only multiple myeloma (LCMM), which accounts for roughly 15-20% of all myeloma cases. In this subtype, your myeloma cells do not produce the fully assembled, heavy proteins that create an M-spike on standard blood tests. Instead, they only produce smaller, incomplete protein fragments called “light chains.” Because these fragments are so small, they usually do not show up as a traditional M-spike, but they can still be accurately diagnosed and tracked using different, highly sensitive tests [1][2]. (Note: Another much rarer subtype called non-secretory myeloma can also result in a zero M-spike, where the cells secrete no proteins at all, but LCMM is far more common).

Understanding “Light Chains” vs. the M-Spike

To understand why your M-spike is zero, it helps to know how antibodies (the proteins produced by healthy plasma cells) are usually built. A normal, complete antibody is shaped like a “Y” and is made of two main parts:

  • Heavy chains: The larger, heavier building blocks.
  • Light chains: The smaller, lighter building blocks attached to the heavy chains.

In classic multiple myeloma, the cancerous plasma cells produce excessive amounts of fully assembled antibodies, which include both heavy and light chains [3][4]. When your blood is tested using a Serum Protein Electrophoresis (SPEP) test, these large, heavy antibodies clump together and show up as a noticeable peak or “M-spike” on the lab report [2][5].

However, in light chain only multiple myeloma, the cancer cells have lost the ability to make the heavy chains. They only pump out the smaller light pieces—specifically known as kappa or lambda light chains [1][2]. Because these light chains are so small, they are rapidly cleared from your bloodstream by your kidneys before they can form a classic M-spike on an SPEP test (unless you have severe kidney impairment, in which case they might accumulate enough to be seen) [2][5]. You will likely also see a test called Immunofixation Electrophoresis (IFE) on your lab report; this is the specific test doctors use to “name” which exact light chain (kappa or lambda) your myeloma is producing [6][1].

How It Is Diagnosed and Monitored

Just because there is no M-spike does not mean the cancer is “invisible” to your doctors. It simply means they have to use different tools to measure it. Patients with light chain only myeloma are monitored just as closely and successfully as patients with classic myeloma [7][8]. While your doctor may still run standard SPEP tests as part of routine lab work, your care team will primarily track your disease using two different tests:

1. Serum Free Light Chain (SFLC) Assay

This is a highly sensitive blood test specifically designed to detect and measure the “free floating” kappa and lambda light chains in your blood [9][10].

  • Why it’s used: The SFLC assay is much more sensitive than an SPEP test and can detect the exact amount of excess light chains your myeloma cells are producing [7][11].
  • The Ratio: Doctors look closely at the ratio between your “involved” (cancerous) light chains and your “uninvolved” (healthy) light chains. Tracking this ratio over time is an excellent way to see how well you are responding to treatment [12][13]. When you check your lab portal, progress typically looks like this ratio dropping steadily toward a normal, balanced range.

2. 24-Hour Urine Test (UPEP)

Because light chains are so small, they are quickly filtered out of your blood by your kidneys and end up in your urine [2][5].

  • Why it’s used: A 24-hour urine test collects all the urine your body produces in a full day to measure the exact amount of light chain proteins (often called Bence-Jones proteins) being excreted [5][6]. (Practical tip: The collection jug usually needs to be kept cold or refrigerated during the 24 hours!)
  • Kidney Protection: Collecting this information is incredibly important because a high volume of light chains passing through the kidneys can damage the kidney’s filtering system over time [12][14]. Checking your urine helps doctors protect your kidney function while treating the myeloma. While SFLC blood tests are becoming the primary way to monitor the disease, 24-hour urine tests remain a vital tool [8][10]. To help protect your kidneys proactively, your care team will likely advise you to stay very well-hydrated to help “flush” these proteins through your system.

Looking Forward

Having a zero M-spike does not mean you have a lesser or separate disease—it just means your myeloma expresses itself differently. Your care team will rely on the SFLC assay and urine tests to give them the same precise picture of your health that an M-spike gives for other patients [11][8].

Frequently Asked Questions

Why is my M-spike zero if I have multiple myeloma?
In light chain only multiple myeloma, the cancer cells do not produce fully assembled antibodies. Instead, they make small protein fragments called light chains that are cleared from the blood too quickly to form a standard M-spike.
How do doctors monitor light chain only multiple myeloma?
Doctors primarily use the Serum Free Light Chain (SFLC) blood assay and 24-hour urine tests to monitor the disease. These highly sensitive tests measure the exact amount of excess light chains your body is producing.
What are kappa and lambda light chains?
Kappa and lambda are the two specific types of light chains produced by myeloma cells. An Immunofixation Electrophoresis (IFE) test is used to identify exactly which type of light chain your cancer is overproducing.
Why do I need to do a 24-hour urine test for myeloma?
Because light chains are very small, your kidneys filter them out of your blood and into your urine. Collecting your urine for a full day allows doctors to measure these proteins, track your disease, and protect your kidney health.
Can light chain myeloma damage my kidneys?
Yes, a high volume of light chain proteins passing through the kidneys can damage their filtering system over time. Your doctor will carefully monitor your kidney function and may recommend drinking extra water to help flush these proteins out.

Questions for Your Doctor

  • Which specific light chain (kappa or lambda) is being overproduced by my myeloma cells?
  • What was my involved-to-uninvolved serum free light chain (SFLC) ratio at diagnosis, and what target ratio are we aiming for?
  • Given that light chains are filtered through the kidneys, what is my current kidney function and do I need to take any special precautions like drinking extra water?
  • How frequently will we be running SFLC blood tests and 24-hour urine tests to monitor my response to treatment?
  • Will you continue to order SPEP and IFE tests routinely, or will we rely entirely on SFLC and urine tests?

Questions for You

  • Have I noticed any changes in my urine output, or experienced any swelling, that might indicate my kidneys are working harder than usual?
  • Am I keeping track of my SFLC ratio trends in my personal medical records so I can follow my progress?
  • Do I fully understand how to properly collect and store a 24-hour urine sample at home to ensure my test results are accurate?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Free Light Chain Multiple Myeloma: Atypical Appearance on Serum Immunofixation.

    Aboudi NE, Ourahma Y, Biaz A, et al.

    Clinical laboratory 2025; (71(9)) doi:10.7754/Clin.Lab.2025.250213.

    PMID: 40923726
  2. 2

    Serum-free light chain test utilisation at a South African academic laboratory and comparison with serum protein electrophoresis results.

    Banderker RB, Fazel FB, Zemlin AE, et al.

    African journal of laboratory medicine 2023; (12(1)):2201 doi:10.4102/ajlm.v12i1.2201.

    PMID: 38058849
  3. 3

    A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interference.

    Mills JR, Kohlhagen MC, Willrich MAV, et al.

    Blood 2018; (132(6)):670-672 doi:10.1182/blood-2018-05-848986.

    PMID: 29891533
  4. 4

    Analysis of Multiple Bands on Serum Protein Immunofixation Electrophoresis: Challenge in Interpretation of Clonality in a Patient with Light Chain-Predominant Multiple Myeloma.

    Nwogbo OV, Jin Y, Sliker T, et al.

    Laboratory medicine 2021; (52(5)):503-508 doi:10.1093/labmed/lmab001.

    PMID: 33693845
  5. 5

    Immunochemical Diagnosis of Multiple Myeloma.

    Lyubimova NV, Timofeev YS, Abaev VM, et al.

    Bulletin of experimental biology and medicine 2018; (165(1)):84-87 doi:10.1007/s10517-018-4105-y.

    PMID: 29797132
  6. 6

    Biochemical profile of Bence-Jones type multiple myeloma.

    Lyubimova NV, Timofeev YS, Abaev VM, et al.

    Klinicheskaia laboratornaia diagnostika 2022; (67(10)):570-574 doi:10.51620/0869-2084-2022-67-10-570-574.

    PMID: 36315171
  7. 7

    [Test of Serum Free Light Chain and Its Clinical Significance in Light Chain Multiple Myeloma].

    Song P, An ZM, Zhou XG, et al.

    Zhongguo shi yan xue ye xue za zhi 2015; (23(5)):1357-61 doi:10.7534/j.issn.1009-2137.2015.05.025.

    PMID: 26524037
  8. 8

    Can urine studies be replaced by serum free light chains measurements to assign responses in multiple myeloma patients?

    Cárdenas MC, Iñigo B, Ortega I, et al.

    Frontiers in oncology 2022; (12()):1056293 doi:10.3389/fonc.2022.1056293.

    PMID: 36531081
  9. 9

    Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas.

    Singh G

    Laboratory medicine 2019; (50(2)):189-193 doi:10.1093/labmed/lmy067.

    PMID: 30423164
  10. 10

    Monitoring of light chain myeloma - time for a change.

    Mollee P, Tate J

    British journal of haematology 2017; (178(2)):177-178 doi:10.1111/bjh.14752.

    PMID: 28695981
  11. 11

    Pee no more? Urine light chains down the drain.

    Mikhael J

    Blood 2016; (128(25)):2873-2874 doi:10.1182/blood-2016-10-746883.

    PMID: 28007729
  12. 12

    Light Chain Multiple Myeloma: High Serum Free Light Chain Concentrations Portend Renal Damage and Poorer Survival.

    Jin Y, Savage NM, Bollag RJ, et al.

    The journal of applied laboratory medicine 2021; (6(6)):1592-1600 doi:10.1093/jalm/jfab090.

    PMID: 34468749
  13. 13

    Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria.

    Narita K, Miura D, Tsushima T, et al.

    Scientific reports 2021; (11(1)):14956 doi:10.1038/s41598-021-94191-8.

    PMID: 34294772
  14. 14

    Light Chain-Predominant Multiple Myeloma Subgroup: Impaired Renal Function Correlates with Decreased Survival.

    Singh G, Savage NM, Jillella AP, Bollag RJ

    Laboratory medicine 2022; (53(2)):145-148 doi:10.1093/labmed/lmab054.

    PMID: 34388245

This page explains lab results and terminology for light chain only multiple myeloma for educational purposes. Always consult your hematologist or oncologist for help interpreting your specific lab test results.

Stay up to date

Get notified when new research about Multiple Myeloma is published.

No spam. Unsubscribe anytime.